218 - S1-RBD Antibodies, SARS-CoV-2 Neutralizing Test
$120.00
S1-RBD Antibodies COV-2 Neutralizing
The S1-RBD Antibodies SARS-CoV-2 Neutralizing test measures neutralizing antibodies that target the receptor-binding domain (RBD) of the SARS-CoV-2 spike (S1) protein. These antibodies play a key role in blocking the virus from binding to human cells and are associated with immune protection against COVID-19.
This test is commonly used to assess immune response following COVID-19 vaccination or prior infection. Unlike standard antibody tests that only detect antibody presence, this test evaluates antibodies with functional neutralizing activity, providing more specific insight into protective immune response.
Results are interpreted in clinical context and are not intended to diagnose active COVID-19 infection.
S1-RBD Antibodies COV-2 Neutralizing
The S1-RBD Antibodies SARS-CoV-2 Neutralizing test measures neutralizing antibodies that target the receptor-binding domain (RBD) of the SARS-CoV-2 spike (S1) protein. These antibodies play a key role in blocking the virus from binding to human cells and are associated with immune protection against COVID-19.
This test is commonly used to assess immune response following COVID-19 vaccination or prior infection. Unlike standard antibody tests that only detect antibody presence, this test evaluates antibodies with functional neutralizing activity, providing more specific insight into protective immune response.
Results are interpreted in clinical context and are not intended to diagnose active COVID-19 infection.
